Prediction of withdrawal symptoms during opioid detoxification

Journal of Opioid Management

Volumn 4, Issue 5, 2008, Pages 311-319

  Dijkstra, Boukje A G ^a,b   Krabbe, Paul F M ^c   De Jong, Cor A J ^a,b   van der Staak, Cees P F ^b  

^a Novadic Kentron   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Detoxification; Opioid; Prediction; Substance dependence; Withdrawal

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLONIDINE; COCAINE; DIAMORPHINE; DIAZEPAM; DICLOFENAC; HALOPERIDOL; METHADONE; MIDAZOLAM; NALTREXONE; NICOTINE PATCH; OCTREOTIDE; ONDANSETRON; OPIATE; SCOPOLAMINE BUTYL BROMIDE;

ADULT; ALCOHOL WITHDRAWAL; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG DETOXIFICATION; EVENING DOSAGE; FEMALE; GENERAL ANESTHESIA; HEROIN DEPENDENCE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NETHERLANDS; OPIATE ADDICTION; PERSONALITY DISORDER; PREDICTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

EID: 57149104397     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2008.0035     Document Type: Article

References (33)

1. Scherbaum N, Klein S, Kaube H, et al.: Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification. Pharmacopsychiatry. 1998; 31(6): 205-209.
2. De Jong CAJ, Laheij RJ, Krabbe PFM: General anaesthesia does not improve outcome in opioid antagonist detoxification treatment: A randomized controlled trial. Addiction. 2005; 100(2): 206-215.
3. Collins ED, Kleber HD, Whittington RA, et al.: Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: A randomized trial. JAMA. 2005; 294(8): 903-913.
4. Gowing LR, Ali R, White J: Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database Syst Rev. 2006(2): CD002022.
5. Bell JR, Young MR, Masterman SC, et al.: A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust. 1999; 171(1): 26-30.
6. Hensel M, Kox WJ: Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: A prospective study in methadone, heroin, codeine and morphine addicts. Acta Anaesthesiol Scand. 2000; 44(3): 326-333.
7. Pfab R, Hirtl C, Zilker T: Opiate detoxification under anesthesia: No apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure. J Toxicol Clin Toxicol. 1999; 37(1): 43-50.
8. Smolka M, Schmidt LG: The influence of heroin dose and route of administration on the severity of the opiate withdrawal syndrome. Addiction. 1999; 94(8): 1191-1198.
9. Farrell M: Opiate withdrawal. Addiction. 1994; 89(11): 1471-1475.
10. Phillips GT, Gossop M, Bradley B: The influence of psychological factors on the opiate withdrawal syndrome. Br J Psychiatry. 1986; 149: 235-238.
11. Kosten TA: Cocaine attenuates the severity of naloxone-precipitated opioid withdrawal. Life Sci. 1990; 47(18): 1617-1623.
12. Rosen MI, Wallace EA, Sullivan MC, et al.: Use of cocaine to prevent opiate withdrawal. Am J Psychiatry. 1992; 149(11): 1609.
13. Becker HC: Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures. Psychopharmacology (Berl). 1994; 116(1): 26-32.
14. Malcolm R, Roberts JS, Wang W, et al.: Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000; 22(3): 159-164.
15. Gerra G, Ceresini S, Esposito A, et al.: Neuroendocrine and behavioural responses to opioid receptor-antagonist during heroin detoxification: relationship with personality traits. Int Clin Psychopharmacol. 2003; 18(5): 261-269.
16. APA: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington, DC: American Psychiatric Association, 2000.
17. Galanter M, Kleber HD: The American Psychiatric Press Textbook of Substance Abuse Treatment, 2nd ed. Washington, DC: American Psychiatric Press, 1999.
18. Handelsman L, Cochrane KJ, Aronson MJ, et al.: Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse. 1987; 13(3): 293-308.
19. Dijkstra BA, Krabbe PF, Riezebos TG, et al.: Psychometric evaluation of the Dutch version of the Subjective Opiate Withdrawal Scale (SOWS). Eur Addict Res. 2007; 13(2): 81-88.
20. Kokkevi A, Hartgers C: EuropASI: European Adaptation of a Multidimensional Assessment Instrument for Drug and Alcohol Dependence. Eur Addict Res. 1995; 4: 208-211.
21. Arrindell WA, Ettema JHM: Klachtenlijst SCL-90 (Symptom Checklist-90). The Netherlands: Lisse: Swets Test Services, 1986.
22. Pfohl B, Blum N, Zimmerman M: Structured Interview for DSM-IV Personality Disorders (SIDP-IV). Washington, DC: American Psychiatric Press, 1997.
23. Damen KF, De Jong CA, van der Kroft PJ: Interrater reliability of the structured interview for DSM-IV personality in an opioid-dependent patient sample. Eur Addict Res. 2004; 10(3): 99-104.
24. Damen KF, De Jong CA, Breteler MH, et al.: Construct validity of the SIDP-IV in an opioid-dependent patient sample. J Subst Use. 2005; 10(1): 1-9.
25. Franken IH, Hendriks VM, van den Brink W: Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict Behav. 2002; 27(5): 675-685.
26. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from incomplete data via the EM algorithm. J Royal Stat Soc Series B (Methodological). 1977; 39(1): 1-38.
27. Krabbe PF: Valuation structures of health states revealed with singular value decomposition. Med Decis Making. 2006; 26(1): 30-37.
28. Department of Health: Drug Misuse and Dependence: Guidelines on clinical management. London: HMSO, 1999.
29. Green S: How many subjects does it take to do: A regression analysis. Multivar Behav Res. 1991; 26(3): 499-510.
30. Gowing LR, Ali RL, White JM: Systematic review processes and the management of opioid withdrawal. Aust N Z J Public Health. 2000; 24(4): 427-431.
31. Gossop M, Bradley B, Phillips GT: An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure. Addict Behav. 1987; 12(1): 1-6.
32. NDM: National Drug Monitor Annual Report 2006. Utrecht, The Netherlands: Trimbos Institute, 2007.
33. NDM: National Drug Monitor Annual Report 2007. Utrecht, The Netherlands: Trimbos Institute, 2008.